Your browser doesn't support javascript.
Outcomes of COVID-19 and risk factors in patients with cancer.
Sengar, Manju; Chinnaswamy, Girish; Ranganathan, Priya; Ashok, Apurva; Bhosale, Shilpushp; Biswas, Sanjay; Chaturvedi, Pankaj; Dhamne, Chetan; Divatia, Jigeeshu; D'Sa, Karishma; Jain, Hasmukh; Laskar, Sarbani; Moulik, Nirmalya Roy; Mummudi, Naveen; Nair, Sindhu; Nayak, Lingaraj; Nayak, Prakash; Patkar, Shraddha; Pawaskar, Preeti; Ramaswamy, Anant; Shetty, Omshree; Singh, Arjun; Sridhar, Epari; Thorat, Jayashree; Badwe, Rajendra; Pramesh, C S.
  • Sengar M; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Chinnaswamy G; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Ranganathan P; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Ashok A; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Bhosale S; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Biswas S; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Chaturvedi P; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Dhamne C; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Divatia J; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • D'Sa K; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Jain H; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Laskar S; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Moulik NR; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Mummudi N; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Nair S; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Nayak L; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Nayak P; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Patkar S; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Pawaskar P; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Ramaswamy A; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Shetty O; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Singh A; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Sridhar E; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Thorat J; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Badwe R; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Pramesh CS; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India. prameshcs@tmc.gov.in.
Nat Cancer ; 3(5): 547-551, 2022 05.
Article in English | MEDLINE | ID: covidwho-1774001
ABSTRACT
Patients with cancer are at higher risk for adverse coronavirus disease 2019 (COVID-19) outcomes. Here, we studied 1,253 patients with cancer, who were diagnosed with severe acute respiratory syndrome coronavirus 2 at a tertiary referral cancer center in India. Most patients had mild disease; in our settings, recent cancer therapies did not impact COVID-19 outcomes. Advancing age, smoking history, concurrent comorbidities and palliative intent of treatment were independently associated with severe COVID-19 or death. Thus, our study provides useful insights into cancer management during the COVID-19 pandemic.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: Nat Cancer Year: 2022 Document Type: Article Affiliation country: S43018-022-00363-4

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: Nat Cancer Year: 2022 Document Type: Article Affiliation country: S43018-022-00363-4